Investment Firm Closes Biotech Stake, SEC Filing
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesA big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
A leading wealth manager just bought a notable position in a small-cap value ETF, highlighting renewed interest in ov...
A new analysis argues zero-down FHA loans for first-time buyers could be feasible with proper underwriting and pricin...
A remote Canadian worksite faced a rare black bear incident that claimed a contractor's life. This article uses the t...
When the AI stock chorus gets loud, picking one winner feels daunting. This article explains why a low-cost AI ETF ca...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
Two defense-focused ETFs offer distinct paths to play defense spending. This guide compares SHLD and ITA on cost, hol...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
A veteran wealth manager makes a bold move into defense stocks as geopolitical tensions rise. Learn the strategy, ris...
Berkshire Hathaway sits on a vast cash cushion, yet the hidden engine that fuels decades of growth runs deeper. This ...
Nuclear expansion plans are accelerating, and uranium ETFs are drawing fresh attention. A look at URA, URNM, URNJ, NL...
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...